Literature DB >> 15972627

B-1 cells are deficient in Lck: defective B cell receptor signal transduction in B-1 cells occurs in the absence of elevated Lck expression.

Rubén Francés1, Joseph R Tumang, Thomas L Rothstein.   

Abstract

B-1 cells constitute a unique B cell subset that is primarily responsible for producing nonimmune Ig. This natural Ig acts as a principal line of defense against infection. A key feature of B-1 cells is the failure of BCR-triggered signal transduction. Recently, defective BCR signaling in B-1 cells has been attributed to elevated expression of the canonical T cell src kinase, Lck. In the present study, we re-examined Lck expression in normal B-1 cells. We found that B-1 cells expressed less Lck at both the protein and RNA levels than did B-2 cells. The same B-1 cells manifested defective BCR-mediated induction of IKKbeta phosphorylation, IkappaBalpha degradation, and intracellular Ca(2+) mobilization. Thus, the failure of BCR signaling in B-1 cells does not relate to subset-specific elevation of Lck.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972627     DOI: 10.4049/jimmunol.175.1.27

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

2.  Fas apoptosis inhibitory molecule expression in B cells is regulated through IRF4 in a feed-forward mechanism.

Authors:  Hiroaki Kaku; Thomas L Rothstein
Journal:  J Immunol       Date:  2009-11-01       Impact factor: 5.422

3.  Potentially autoreactive naturally occurring transitional T3 B lymphocytes exhibit a unique signaling profile.

Authors:  Ganna A Liubchenko; Holly C Appleberry; V Michael Holers; Nirmal K Banda; Van C Willis; Taras Lyubchenko
Journal:  J Autoimmun       Date:  2012-02-24       Impact factor: 7.094

4.  Continual signaling is responsible for constitutive ERK phosphorylation in B-1a cells.

Authors:  Nichol E Holodick; Joseph R Tumang; Thomas L Rothstein
Journal:  Mol Immunol       Date:  2009-07-09       Impact factor: 4.407

5.  Fas apoptosis inhibitory molecule enhances CD40 signaling in B cells and augments the plasma cell compartment.

Authors:  Hiroaki Kaku; Thomas L Rothstein
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

6.  Adult BM generates CD5+ B1 cells containing abundant N-region additions.

Authors:  Nichol E Holodick; Karen Repetny; Xuemei Zhong; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

7.  Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13.

Authors:  Rajatava Basu; Suniti Bhaumik; Arun Kumar Haldar; Kshudiram Naskar; Tripti De; Syamal Kumar Dana; Peter Walden; Syamal Roy
Journal:  Infect Immun       Date:  2007-10-01       Impact factor: 3.441

8.  CD19 signaling is impaired in murine peritoneal and splenic B-1 B lymphocytes.

Authors:  Trivikram Dasu; Vishal Sindhava; Stephen H Clarke; Subbarao Bondada
Journal:  Mol Immunol       Date:  2009-06-21       Impact factor: 4.407

9.  Potential role of viral infection and B cells as a linker between innate and adaptive immune response in systemic lupus erythematosus.

Authors:  Mohadeseh Zarei Ghobadi; Shima Izadi; Majid Teymoori-Rad; Mohammad Farahmand; Sayed-Hamidreza Mozhgani; Negar Labbaf; Fazel Shokri; Sayed Mahdi Marashi
Journal:  Immunol Res       Date:  2021-03-30       Impact factor: 2.829

10.  Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter.

Authors:  H Kaku; T L Rothstein
Journal:  Genes Immun       Date:  2009-08-27       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.